tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MESO Stock Latest News

Mesoblast collaborating with BMT CTN on trial of Ryoncil in acute GvHD
The FlyMesoblast collaborating with BMT CTN on trial of Ryoncil in acute GvHD
2d ago
MESO
Mesoblast appoints James O’Brien as CFO
PremiumThe Fly
Mesoblast appoints James O’Brien as CFO
5d ago
ABBV
MESO
Mesoblast Announces Director’s Share Acquisition and New Equity Issuance
PremiumCompany Announcements
Mesoblast Announces Director’s Share Acquisition and New Equity Issuance
24d ago
6K
MESO
Mesoblast’s Promising Study on Chronic Low Back Pain Treatment: A Market Game Changer?
PremiumCompany Announcements
Mesoblast’s Promising Study on Chronic Low Back Pain Treatment: A Market Game Changer?
26d ago
MESO
Mesoblast Reports Strong Revenue Growth with Ryoncil® Adoption
PremiumCompany Announcements
Mesoblast Reports Strong Revenue Growth with Ryoncil® Adoption
1M ago
6K
MESO
Mesoblast reports Q2 Ryoncil revenue up 66% y/y
PremiumThe FlyMesoblast reports Q2 Ryoncil revenue up 66% y/y
2M ago
MESO
Mesoblast receives J-Code for Ryoncil from Medicare & Medicaid Services
Premium
The Fly
Mesoblast receives J-Code for Ryoncil from Medicare & Medicaid Services
2M ago
MESO
Mesoblast’s U.S. Origin Designation Shields Products from Tariffs
Premium
Company Announcements
Mesoblast’s U.S. Origin Designation Shields Products from Tariffs
2M ago
6K
MESO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
BNC
MBX
Buy Rating for Mesoblast Driven by Strong Ryoncil Launch and Strategic Financial Moves
PremiumRatings
Buy Rating for Mesoblast Driven by Strong Ryoncil Launch and Strategic Financial Moves
3M ago
MESO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
3M ago
SU
LIT
Mesoblast’s Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Mesoblast’s Earnings Call Highlights Growth and Challenges
3M ago
MESO
Mesoblast falls -12.9%
PremiumThe FlyMesoblast falls -12.9%
3M ago
MESO
Mesoblast falls -12.5%
Premium
The Fly
Mesoblast falls -12.5%
3M ago
MESO
Mesoblast Limited Reports 2025 Earnings and Strategic Outlook
Premium
Company Announcements
Mesoblast Limited Reports 2025 Earnings and Strategic Outlook
3M ago
MESO
Mesoblast reports FY25 net loss ($102.1M) vs. ($88.0M) last year
PremiumThe Fly
Mesoblast reports FY25 net loss ($102.1M) vs. ($88.0M) last year
3M ago
MESO
Mesoblast options imply 11.6% move in share price post-earnings
PremiumThe Fly
Mesoblast options imply 11.6% move in share price post-earnings
3M ago
MESO
Mesoblast downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Mesoblast downgraded to Hold from Buy at Jefferies
4M ago
MESO
Mesoblast reports Q1 Ryoncil gross revenue $13.2M
PremiumThe Fly
Mesoblast reports Q1 Ryoncil gross revenue $13.2M
4M ago
MESO
Mesoblast Announces Cessation of Securities and Capital Adjustments
PremiumCompany AnnouncementsMesoblast Announces Cessation of Securities and Capital Adjustments
4M ago
6K
MESO
Buy Rating for Mesoblast: FDA Alignment and Promising Revascor Data Drive Optimism
Premium
Ratings
Buy Rating for Mesoblast: FDA Alignment and Promising Revascor Data Drive Optimism
5M ago
MESO
Mesoblast gives update on Revascor accelerated approval, Ryoncil label extension
Premium
The Fly
Mesoblast gives update on Revascor accelerated approval, Ryoncil label extension
5M ago
MESO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >